Skip NavigationSkip to Content

Reverse-phase protein lysate microarrays for cell signaling analysis

  1. Author:
    Spurrier, B.
    Ramalingam, S.
    Nishizuka, S.
  2. Author Address

    Spurrier, Brett, Nishizuka, Satoshi] NCI, Mol Translat Technol Sect, Mol Therapeut Program, NIH, Bethesda, MD 20892 USA. [Spurrier, Brett] Aushon BioSyst, Billerica, MA 01821 USA. [Ramalingam, Sundhar] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA. [Nishizuka, Satoshi] NCI, Lab Prote & Analyt Technol, SAIC Frederick Inc, Frederick, MD 21702 USA. [Nishizuka, Satoshi] Iwate Med Univ, Dept Surg, Mol Therapeut Lab, Morioka, Iwate 0208505, Japan.
    1. Year: 2008
  1. Journal: Nature Protocols
    1. 3
    2. 11
    3. Pages: 1796-1808
  2. Type of Article: Article
  1. Abstract:

    'Reverse-phase' protein lysate microarray (RPA) assays use micro-scale, cell lysate dot blots that are printed to a substrate, followed by quantitative immunochemical protein detection, known to be particularly effective across many samples. Large-scale sample collection is a labor-intensive and time-consuming process, the information yielded from RPA assays, however, provides unique opportunities to experimentally interpret theoretical protein networks quantitatively. When specific antibodies are used, RPA can generate 1,000 times more data points using 10,000 times less sample volume than an ordinary western blot, enabling researchers to monitor quantitative proteomic responses for various time-scale and input-dose gradients simultaneously. Hence, the RPA system can be an excellent method for experimental validation of theoretical protein network models. Besides the initial screening of primary antibodies, collection of several hundreds of sample lysates from 1- to 8-h periods can be completed in similar to 10 d, subsequent RPA printing and signal detection steps require an additional 2-3 d.

    See More

External Sources

  1. DOI: 10.1038/nprot.2008.179
  2. PMID: 18974738

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel